Euglycemic Diabetic Ketoacidosis Secondary to SGLT2-inhibitor Use in Combination With a Ketogenic Diet

Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are cardiorenal protective agents increasingly used in patients with diabetes. Cases of euglycemic diabetic ketoacidosis (euDKA) have been reported particularly among patients with type 1 diabetes. Our case is an example that highlights the role SGL...

Descripción completa

Detalles Bibliográficos
Autores principales: Hester, Joi C, Zimmerman, Stacy, Nimmo, Teresa Allison, Cunningham, Wesley, Liu, Joshua, Sukpraprut-Braaten, Suporn, Pasquel, Francisco J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Diabetes Mellitus and Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089890/
http://dx.doi.org/10.1210/jendso/bvab048.776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089890/
http://dx.doi.org/10.1210/jendso/bvab048.776

Ejemplares similares